{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:32:56Z","timestamp":1794717176687,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:00:00Z","timestamp":1719100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.psychres.2024.116049","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:24:17Z","timestamp":1718987057000},"page":"116049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"339","author":[{"given":"Kevin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Chu-Han","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2024.116049_bib0001","doi-asserted-by":"crossref","first-page":"d1199","DOI":"10.1136\/bmj.d1199","article-title":"Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis","volume":"342","author":"Baldwin","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.psychres.2024.116049_bib42","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"issue":"6","key":"10.1016\/j.psychres.2024.116049_bib0002","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.psychres.2024.116049_bib35","doi-asserted-by":"crossref","first-page":"21m14130","DOI":"10.4088\/JCP.21m14130","article-title":"Cannabidiol for treatment-resistant anxiety disorders in young people: an open-label trial","volume":"83","author":"Berger","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2024.116049_bib0003","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.psychres.2024.116049_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1590\/1516-4446-2021-2317","article-title":"The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event","volume":"44","author":"Bolsoni","year":"2022","journal-title":"Br. J. Psychiatry"},{"issue":"14","key":"10.1016\/j.psychres.2024.116049_bib0004","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.3390\/molecules24142583","article-title":"Cannabidiol treatment might promote resilience to cocaine and methamphetamine use disorders: a review of possible mechanisms","volume":"24","author":"Calpe-Lopez","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.psychres.2024.116049_bib0005","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Guimaraes FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B. Biol. Sci."},{"issue":"2","key":"10.1016\/j.psychres.2024.116049_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2024.116049_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.psychres.2024.116049_bib0007","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r12064","article-title":"Efficacy and tolerability of pharmacotherapy for pediatric anxiety disorders: a network meta-analysis","volume":"80","author":"Dobson","year":"2019","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2024.116049_bib0008","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.drugpo.2015.09.005","article-title":"Addressing the stimulant treatment gap: a call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use","volume":"26","author":"Fischer","year":"2015","journal-title":"Int. J. Drug. Policy"},{"issue":"4","key":"10.1016\/j.psychres.2024.116049_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.psycom.2022.100074","article-title":"Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety","volume":"2","author":"Fliegel","year":"2022","journal-title":"Psychiatry Res. Commun."},{"issue":"10","key":"10.1016\/j.psychres.2024.116049_bib0010","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2024.116049_bib0009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamapsychiatry.2013.4186","article-title":"Naturalistic follow-up of youths treated for pediatric anxiety disorders","volume":"71","author":"Ginsburg","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2024.116049_bib36","series-title":"Cannabidiol Reduces Nicotine Withdrawal Severity and State Anxiety During an Acute E-cigarette Abstinence Period: A Novel, Open-Label Study","author":"Gournay","year":"2023"},{"key":"10.1016\/j.psychres.2024.116049_bib0011","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101010","article-title":"Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand","volume":"4","author":"Gulbransen","year":"2020","journal-title":"BJGP Open"},{"issue":"1","key":"10.1016\/j.psychres.2024.116049_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.psychres.2024.116049_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.psychres.2024.116049_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0269881117737400","article-title":"The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group","volume":"32","author":"Hundal","year":"2018","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"11","key":"10.1016\/j.psychres.2024.116049_bib0013","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116049_bib0015","article-title":"Cognitive behavioural therapy for anxiety disorders in children and adolescents","volume":"2","author":"James","year":"2015","journal-title":"Cochran. Databas Syst. Rev."},{"key":"10.1016\/j.psychres.2024.116049_bib0016","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archgenpsychiatry.2011.160","article-title":"Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement","volume":"69","author":"Kessler","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116049_bib0017","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-0327(01)00354-8","article-title":"Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database","volume":"68","author":"Khan","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2024.116049_bib0018","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.psychres.2024.116049_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2021.102429","article-title":"Practical considerations for testing the effects of cannabidiol on human anxiety","volume":"82","author":"Leen-Feldner","year":"2021","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.psychres.2024.116049_bib0021","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1176\/appi.ajp.2014.13030418","article-title":"Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis","volume":"172","author":"Lin","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2024.116049_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116049_bib39","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.psychres.2024.116049_bib0022","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/eip.12274","article-title":"Anxiety in youth at clinical high risk for psychosis","volume":"11","author":"McAusland","year":"2017","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116049_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102935","article-title":"Access to cannabidiol without a prescription: a cross-country comparison and analysis","volume":"85","author":"McGregor","year":"2020","journal-title":"Int. J. Drug. Policy"},{"key":"10.1016\/j.psychres.2024.116049_bib0023","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and Delta (9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2024.116049_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/da.20182","article-title":"Development and validation of an Overall Anxiety Severity And Impairment Scale (OASIS)","volume":"23","author":"Norman","year":"2006","journal-title":"Depress. Anxiety"},{"issue":"2","key":"10.1016\/j.psychres.2024.116049_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(71)90039-6","article-title":"The action of sedatives on brain stem oculomotor systems in man","volume":"10","author":"Norris","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2024.116049_bib0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cpr.2007.01.015","article-title":"Quality of life in the anxiety disorders: a meta-analytic review","volume":"27","author":"Olatunji","year":"2007","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.psychres.2024.116049_bib0027","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.116049_bib0026","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/0269881113485144","article-title":"Cooperative regulation of anxiety and panic-related defensive behaviors in the rat periaqueductal grey matter by 5-HT1A and mu-receptors","volume":"27","author":"Roncon","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.116049_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Permanente J."},{"issue":"1","key":"10.1016\/j.psychres.2024.116049_bib0028","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.japh.2019.11.008","article-title":"Use of cannabidiol in anxiety and anxiety-related disorders","volume":"60","author":"Skelley","year":"2020","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.psychres.2024.116049_bib46","series-title":"State-trait anxiety inventory for adults","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.psychres.2024.116049_bib0029","first-page":"611","article-title":"The diagnosis and treatment of anxiety disorders","volume":"155","author":"Str\u00f6hle","year":"2018","journal-title":"Dtsch. Aerzteblatt. Online"},{"issue":"1","key":"10.1016\/j.psychres.2024.116049_bib0031","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/157488912798842269","article-title":"Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives","volume":"7","author":"Tambaro","year":"2012","journal-title":"Recent Pat. CNS Drug. Discov."},{"issue":"4","key":"10.1016\/j.psychres.2024.116049_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2361","article-title":"Alcohol or benzodiazepine Coinvolvement with opioid overdose deaths in the United States, 1999-2017","volume":"3","author":"Tori","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.psychres.2024.116049_bib44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1037\/h0027806","article-title":"Measurement of social-evaluative anxiety","volume":"33","author":"Watson","year":"1969","journal-title":"J. Consult. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.psychres.2024.116049_bib0032","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2024.116049_bib0033","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped doseresponse curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124003342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124003342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T20:55:47Z","timestamp":1733172947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178124003342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":46,"alternative-id":["S0165178124003342"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116049","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116049"}}